Gildan Q1 Revenue Surges on HanesBrands Consolidation; Integration on Track

What happened

Gildan reported record Q1 2026 net sales of $1.17 billion, up 63.8% year-over-year, driven primarily by the first full quarter of HanesBrands consolidation. Adjusted operating margin came in at 14.3%, and adjusted EPS was $0.43, though GAAP results showed a loss due to acquisition-related costs. Management reiterated full-year 2026 guidance and remains on pace to realize approximately $100 million in synergies this year, with $250 million annual run-rate targeted within three years. The revenue headline looks impressive, but investors should note that organic underlying growth is masked by the acquisition; the adjusted margin also benefited from one-time items and cost shifts. Execution risk persists around synergy delivery, tariff exposure, and UFLPA compliance, even as the company’s cost leadership model provides a stable foundation.

Implication

The Q1 2026 report validates the synergy thesis from the HanesBrands acquisition, with management confidently guiding to $100M in year-one savings. However, the 63.8% revenue growth is almost entirely M&A-driven, and organic Activewear growth (previously ~12% in Q2 2025) is not separately quantified. Adjusted operating margin of 14.3% is solid but may not be fully recurring due to purchase accounting adjustments. For long-term holders, the key is whether Gildan can sustain margin expansion while de-levering from ~$2B debt. The maintained guidance implies confidence in second-half performance, but any slowdown in consumer spending, tariff hikes, or integration hiccups could pressure the stock. Given the reasonable 15-17x forward P/E and FCF >$450M guide, the risk/reward remains favorable for patient investors, albeit with near-term noise.

Thesis delta

The Q1 results are broadly in line with the existing BUY thesis, confirming that the HanesBrands integration is progressing and that margins are holding. No material shift is warranted: the core thesis around cost leadership, synergy capture, and FCF generation remains intact. However, the near-term focus should shift from deal announcement risk to execution proof points, making the stock more dependent on operational delivery than binary regulatory outcomes.